Morgan Stanley Initiates Coverage on Mindray Medical (MR) with an Overweight
More News related to MR
- Mindray Medical International Announces Second Quarter 2008 Results
- Mindray Medical (MR) Appoints Liu as COO
- Mindray Appoints Jie Liu as Chief Operating Officer
- Mindray Releases Historical Financial Results Converted into US Dollar Terms
- Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
Morgan Stanley initiates coverage on Mindray Medical (NYSE: MR) with an Overweight. Price target $50.
Mindray Medical International Limited is developer, manufacturer and marketer of medical devices in China.
Related Categories
New CoverageStocks Mentioned
+0.39Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
